Pharmafile Logo
Pharmafocus logo
Advanced Search

Lilly names new VP of communications

September 23, 2010
Medical Communications appointment, lilly, medical communications

Jeffrey Winton will next month join Lilly as vice president of communications and take a place on the company’s global …

Appointment

Gilenya approved as new frontline MS treatment

September 22, 2010
Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya

Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …

News

Lixisenatide shaping up to rival Victoza

September 22, 2010
Research and Development Lixisenatide, Sanofi-Aventis, diabetes

Data for Sanofi-Aventis’ injectable lixisenatide suggests it could rival Novo Nordisk’s drug Victoza.Lixisenatide is a once-daily GLP-1 receptor agonist, and …

News

Outdated HRT website breaches Code

September 22, 2010
Medical Communications ABPI, Code of Practice, PMCPA, Pfizer, Wyeth

A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …

News

Tesco to sell cut-price Viagra

September 21, 2010
Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra

Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …

News
Blog footer

Digital Pharma: GSK takes drug information to Europe

September 21, 2010
Medical Communications Digital Pharma blog, GlaxoSmithKline, digital patients

European patients can now get information on GlaxoSmithKline’s prescription medicines direct from the company through its expanded health.gsk.com website. The …

News

J&J’s Weldon will appear at next congressional hearing

September 21, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …

News
Vicky_White

Red Door boosts consumer health division

September 21, 2010
Medical Communications Red Door, appointment, medical communications

London-based healthcare communications consultancy Red Door has boosted its consumer health division with two senior appointments. Rachel Vrettos has returned …

Appointment

AAIPharma appoints Patrick Walsh

September 21, 2010
Manufacturing and Production AAIPharma, appointment, manufacturing and production

Contract manufacturing and drug development services company AAIPharma has appointed Patrick Walsh as its new chief executive. Walsh has 30 …

Appointment

Medical, marketing & sales: making cross-functional working work

September 21, 2010
Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives

A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …

Feature

Pharma manufacturing news in brief

September 21, 2010
Manufacturing and Production AAIPharma, Actavis, Japan, KV Pharmaceutical, Purac, Takeda, contract manufacturing

This week’s round-up of pharmaceutical manufacturing news includes updates from Takeda, KV Pharmaceutical, Actavis, AAIPharma and Purac, while Japan’s CMOs …

News

Public sceptical of pharma research

September 21, 2010
Research and Development Animal testing, Animal tests

Businesses including drug companies are seen as broadly untrustworthy or self-serving when it comes to medical research. This is one …

News

Transition drops new diabetes drug

September 20, 2010
Research and Development Transition Therapeutics, diabetes, lilly

Transition Therapeutics is to abandon trials of its new diabetes treatment TT-223 following disappointing trial results. The Canadian biopharma company …

News

FDA launches safety review of Actos

September 20, 2010
Sales and Marketing Actos, Takeda, diabetes

A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …

News

Novartis hails longer-lasting COPD drug

September 20, 2010
Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler

A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …

News

1 in 4 UK doctors use Doctors.net.uk’s online professional network each day

September 20, 2010
Medical Communications Doctors.net.uk, doctors, online, professional networks, tala

 

News
Press release
GlaxoSmitKline logo

GSK workers in Ireland await review

September 20, 2010
Manufacturing and Production, Research and Development GlaxoSmithKline, Ireland, job cuts

Workers at a GlaxoSmithKline facility in Ireland are anxiously awaiting the outcome of an official review of the operation amid …

News

Realising outsourcing’s potential

September 20, 2010
Sales and Marketing Kinapse, White paper

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …

Feature
White paper
Alan_Watt

Cellzome hires GSK’s Alan Watt

September 20, 2010
Research and Development Cellzome, appointment, research and development

Cambridge, UK-based drug discovery and development company Cellzome has appointed Alan Watt to its senior management team as vice president …

Appointment

Contract research news in brief

September 20, 2010
Research and Development Covance, Galapagos, MediData Solutions, MediSync BioServices, PPD, Quotient Bioresearch, i3

A round-up of recent news from the CRO sector, featuring updates from Covance, Quotient Bioresearch, PPD, i3, Galapagos, MediSync BioServices …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026